Last quarter (Q0 0), Propanc Biopharma's total revenue was $―, a decrease of ― from the same quarter last year. In Q0, Propanc Biopharma's net income was $-354.31K. See Propanc Biopharma’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Jun 24	Jun 23	Jun 22	Jun 21	Jun 20
Total Revenue	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Cost of Revenue	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Gross Profit	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Operating Expense	$ 1.41M	$ 1.54M	$ 1.78M	$ 1.99M	$ 1.81M	$ 3.49M
Operating Income	$ -1.41M	$ -1.54M	$ -1.78M	$ -1.99M	$ -1.81M	$ -3.49M
Net Non Operating Interest Income Expense	$ 178.28K	$ 60.00	$ 36.00	$ -563.18K	$ -449.46K	$ -1.75M
Other Income Expense	$ -152.05K	$ -371.10K	$ 504.36K	$ -159.01K	$ -91.74K	$ -510.05K
Pretax Income	$ -1.95M	$ -1.95M	$ -2.79M	$ -2.71M	$ -2.14M	$ -4.88M
Tax Provision	$ -129.13K	$ -129.13K	$ -129.84K	$ -54.98K	$ -113.42K	$ -134.73K
Earnings From Equity Interest Net Of Tax	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Net Income Common Stockholders	$ -1.87M	$ -2.01M	$ -3.13M	$ -3.36M	$ -2.42M	$ -4.74M
Basic EPS	$ 0.02	$ -0.02	$ -1.80	$ -50.00	$ -800.00	$ -190.00K
Diluted EPS	$ 0.02	$ -0.02	$ -1.80	$ -50.00	$ -800.00	$ -190.00K
Basic Average Shares	$ 920.13M	$ 85.05M	$ 1.74M	$ 68.22K	$ 3.03K	$ 24.00
Diluted Average Shares	$ 920.13M	$ 85.05M	$ 1.74M	$ 68.22K	$ 3.03K	$ 24.00
Dividend Per Share	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Operating Income As Reported	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Basic E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Diluted E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Rent Expense Supplemental	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Expenses	$ 1.41M	$ 1.54M	$ 1.78M	$ 1.99M	$ 1.81M	$ 3.49M
Net Income From Continuing And Discontinued Operation	$ -1.82M	$ -1.82M	$ -2.66M	$ -2.66M	$ -2.03M	$ -4.74M
Normalized Income	$ -1.55M	$ -2.08M	$ ―	$ ―	$ ―	$ ―
Interest Expense	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
EBIT	$ -1.56M	$ -1.95M	$ -2.79M	$ -2.14M	$ -1.69M	$ -3.13M
EBITDA	$ -1.58M	$ -1.63M	$ -2.23M	$ -2.14M	$ -1.69M	$ -3.12M

Currency in USD

Propanc Biopharma Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing